JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.57B |
| 2 |
Amazon
AMZN
|
+$2.84B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.47B |
| 4 |
Mastercard
MA
|
+$1.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$4.44B |
| 2 |
Apple
AAPL
|
+$3.14B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.87B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.84B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.57B |
Sector Composition
| 1 | Technology | 20.05% |
| 2 | Healthcare | 11.18% |
| 3 | Financials | 9.56% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Industrials | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RRAC
3026
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $1.47M | ﹤0.01% |
+135,000
| New | +$1.47M |
|
3027
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$1.15B
| $1.47M | ﹤0.01% |
+64,831
| New | +$1.47M |
|
3028
Embecta
EMBC
$887M
| $1.47M | ﹤0.01% |
97,445
-8,429
| -8% | -$127K |
|
3029
N-able
NABL
$1.58B
| $1.47M | ﹤0.01% |
113,647
-44,340
| -28% | -$572K |
|
|
BFS
3030
Saul Centers
BFS
$789M
| $1.46M | ﹤0.01% |
41,393
+1,120
| +3% | +$39.5K |
|
|
AYX
3031
DELISTED
Alteryx, Inc.
AYX
| $1.46M | ﹤0.01% |
38,705
-14,564
| -27% | -$549K |
|
3032
Core Laboratories
CLB
$595M
| $1.46M | ﹤0.01% |
60,606
-6,041
| -9% | -$145K |
|
3033
Vir Biotechnology
VIR
$720M
| $1.45M | ﹤0.01% |
154,990
-78,529
| -34% | -$736K |
|
3034
Dimensional Emerging Markets High Profitability ETF
DEHP
$290M
| $1.44M | ﹤0.01% |
63,781
+4,441
| +7% | +$101K |
|
3035
Hain Celestial
HAIN
$135M
| $1.44M | ﹤0.01% |
139,214
-1,239,473
| -90% | -$12.9M |
|
3036
dMY Squared
DMYY
$52.3M
| $1.44M | ﹤0.01% |
+137,850
| New | +$1.44M |
|
3037
First Mid Bancshares
FMBH
$970M
| $1.44M | ﹤0.01% |
54,196
-6,801
| -11% | -$181K |
|
|
NIR
3038
DELISTED
Near Intelligence, Inc. Common Stock
NIR
| $1.43M | ﹤0.01% |
5,852,099
| – | – |
|
3039
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.1B
| $1.43M | ﹤0.01% |
9,767
+927
| +10% | +$136K |
|
3040
LegalZoom.com
LZ
$2B
| $1.43M | ﹤0.01% |
130,416
-214,404
| -62% | -$2.35M |
|
3041
Terns Pharmaceuticals
TERN
$716M
| $1.42M | ﹤0.01% |
283,135
-98,480
| -26% | -$495K |
|
|
ADAM
3042
Adamas Trust, Inc. Common Stock
ADAM
$668M
| $1.42M | ﹤0.01% |
167,676
-12,060
| -7% | -$102K |
|
3043
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$379M
| $1.42M | ﹤0.01% |
52,565
-1,487
| -3% | -$40.2K |
|
3044
Lifestance Health
LFST
$2.09B
| $1.42M | ﹤0.01% |
206,885
-110,197
| -35% | -$757K |
|
3045
Pliant Therapeutics
PLRX
$91.5M
| $1.42M | ﹤0.01% |
81,846
+8,649
| +12% | +$150K |
|
|
CSTR
3046
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.42M | ﹤0.01% |
99,760
-10,501
| -10% | -$149K |
|
3047
WisdomTree US Multifactor Fund
USMF
$426M
| $1.42M | ﹤0.01% |
36,796
+1,244
| +3% | +$47.8K |
|
3048
Expro
XPRO
$1.43B
| $1.41M | ﹤0.01% |
60,907
-226,871
| -79% | -$5.27M |
|
|
API
3049
Agora
API
$353M
| $1.41M | ﹤0.01% |
557,412
-1,376,627
| -71% | -$3.48M |
|
3050
Arcus Biosciences
RCUS
$1.32B
| $1.41M | ﹤0.01% |
78,319
-1,481
| -2% | -$26.6K |
|